Giampietro Gasparini

Rome, 00135, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.

Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.

Journal: Cancers

Published: July 14, 2025

Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.

Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 16, 2024

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.

A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.

Journal: Cancers

Published: August 14, 2023

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 29, 2022

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer.

Journal: Cancers

Published: July 04, 2022

Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: September 23, 2020

Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models.

Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models.

Journal: Pharmaceutics

Published: June 11, 2020

Thrombin generation predicts early recurrence in breast cancer patients.

Thrombin generation predicts early recurrence in breast cancer patients.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 26, 2019

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.

Journal: Haematologica

Published: June 07, 2019

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.

Journal: Clinical breast cancer

Published: October 01, 2018

Frizzled-10 and cancer progression: Is it a new prognostic marker?

Frizzled-10 and cancer progression: Is it a new prognostic marker?

Journal: Oncotarget

Published: September 08, 2017

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

Journal: International journal of cancer

Published: March 22, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026